Issuing such equity would not necessarily harm the firm—it could even rescue it. The negative reaction may come from your investors learning (possibly correctly) that something bad has recently happened—

for example, your R&D has failed. To rescue the firm’s valuable projects, your best choice would still be to obtain more funding despite the negative reaction.